Presentation:<\/u><\/p>\n
NovaSeq \u2013 the Next Era Sequencing Technology<\/p>\n
Abstract:<\/u><\/p>\n
With the genomics field evolving at light speed, innovation is key to keep this development alive. Illumina is constantly improving their products and widening the portfolio to give researchers and clinicians access to new information in a multitude of applications.<\/p>\n
NovaSeq 6000 Sequencing System unleashes a new era in sequencing with groundbreaking innovations that leverage proven Illumina next generation sequencing (NGS) technology. It provides users with the throughput, speed, and flexibility to complete projects faster and more economically than ever before. Applications requiring large amounts of data, such as human whole genome sequencing (WGS), ultra-deep exome sequencing, and tumor-normal profiling can now be completed in a more cost-effective manner. The same instrument can be used for less data-intensive methods, such as targeted resequencing. The recent introduction of NovaSeq S4 flow cell and NovaSeq Xp workflow delivers up to 6TB of output in two days and additional flexibility to allow project combination. All these extend the capabilities of the platform to empower high intensity sequencing across a wide range of sequencing methods. Every project or task, regardless of the size or goal, will benefit from its simple load-and-go operation, integrated onboard cluster generation, and seamless integration with data storage and analysis tools that help streamline the overall workflow.<\/p>\n
Illumina is playing a crucial role in transforming the way we will be doing research and looking at patients in the future, being the market leader in genomics and following a single vision: To improve human health by unlocking the power of the\u00a0genome!<\/p>\n
<\/p>\n","protected":false},"excerpt":{"rendered":"
Presentation: NovaSeq \u2013 the Next Era Sequencing Technology Abstract: With the genomics field evolving at light speed, innovation is key to keep this development alive. …<\/a><\/p>\n","protected":false},"author":1001007,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[13],"tags":[],"class_list":["post-7179","post","type-post","status-publish","format-standard","hentry","category-uncategorized-en"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t